Mikhail Blagosklonny is a researcher of oncology. He is based in New York, at the Roswell Park Cancer Institute. Mikhail studied at the University of St. Petersburg where he graduated with his Medical Doctorate and Philosophy Degree. He particularly focused on cardiology and experimental medicine. After his studies, he was first appointed at New York Medical College as an associate professor. Afterwards, he joined Ordway Research Institute where he served as a senior scientist until 2009. During the same year, he was appointed to his current position at Roswell Park. Blagosklonny has deep interest in researching about cancer, its treatment, and developing drugs that can protect normal cells in the body. He also researches on aging-related diseases.
Blagosklonny is the chief editor of three widely read journals, which are Cell Cycle, Oncotarget and Aging. In addition, the scientist offers innovative insights to Cell Death and Differentiation where he serves on the editorial board. He has also made significant contributions at Cancer Biology and Therapy where he is an associate editor. Moreover, he has published more than 270 papers in varied journals where he has listed citations that exceed 25,000. Blagosklonny has a wide range of skills relating to Cancer Therapy, Apoptosis, Cancer Cell Biology, Signal Transduction, Protein Kinases, Cell Proliferation, Phosphorylation, and Cell Division among others.
At Cancer Institute of Roswell Park, Mikhail Blagosklonny has used his transformative style of leadership to enhance the growth of the institution. He has managed to expand the methods of cancer prevention, treatment and other anticancer strategies. He has also shared many ideas with other members at the institution, including the different ways of protecting normal cells from electrochemical therapies and special tissue treatment. Additionally, Mikhail has made significant contributions on the right combination of cancer drugs and mechanisms of slowing down the aging of organisms through cancer prevention. Read more on Impact Journals.
Blagosklonny is a well-known researcher who has developed exceptional methods of cancer prevention and treatment. He has extended his research to include the treatment of cancer and aging-related diseases. His publications have been of great help to the company, scientists, readers and the public at large. As a professor of oncology, Mikhail continues to engage in extensive research processes.